Effects of Dapagliflozin on the Urinary Albumin-to-Creatinine Ratio in Patients with Type 2 Diabetes: A Predefined Analysis from the DECLARE-TIMI 58 Randomised, Placebo-Controlled Trial

Citation
Raz I, Wiviott SD, Yanuv I, et al. Diabetes 2019;68(Suppl 1):244-OR.